BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16291077)

  • 1. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease.
    Celli BR; Calverley PM; Rennard SI; Wouters EF; Agusti A; Anthonisen N; Macnee W; Jones P; Pride N; Rodriguez-Roisin R; Rossi A; Wanner A
    Respir Med; 2005 Dec; 99(12):1546-54. PubMed ID: 16291077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
    Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J
    Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
    Celli BR; Cote CG; Marin JM; Casanova C; Montes de Oca M; Mendez RA; Pinto Plata V; Cabral HJ
    N Engl J Med; 2004 Mar; 350(10):1005-12. PubMed ID: 14999112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.
    Medinas Amorós M; Mas-Tous C; Renom-Sotorra F; Rubí-Ponseti M; Centeno-Flores MJ; Gorriz-Dolz MT
    Chron Respir Dis; 2009; 6(2):75-80. PubMed ID: 19411567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study.
    Montes de Oca M; Tálamo C; Perez-Padilla R; Jardim JR; Muiño A; Lopez MV; Valdivia G; Pertuzé J; Moreno D; Halbert RJ; Menezes AM;
    Respir Med; 2008 May; 102(5):642-50. PubMed ID: 18314321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
    Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
    Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary function in first generation children of chronic obstructive pulmonary disease (COPD) patients: assessment of related predicting factors].
    Lu B; He Q; Chen Q; Huang X; Li J
    Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1136-9. PubMed ID: 12425829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global assessment of the COPD patient: time to look beyond FEV1?
    Papaioannou AI; Loukides S; Gourgoulianis KI; Kostikas K
    Respir Med; 2009 May; 103(5):650-60. PubMed ID: 19167871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future perspectives in COPD.
    Celli B; Goldstein R; Jardim J; Knobil K
    Respir Med; 2005 Dec; 99 Suppl B():S41-8. PubMed ID: 16256325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring the effects of COPD on the patient.
    Jones P; Lareau S; Mahler DA
    Respir Med; 2005 Dec; 99 Suppl B():S11-8. PubMed ID: 16236492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality in COPD.
    Celli BR
    Respir Med; 2010 Jun; 104(6):773-9. PubMed ID: 20417082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
    Fan VS; Ramsey SD; Make BJ; Martinez FJ
    COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities as an element of multidimensional prognostic assessment of patients with chronic obstructive pulmonary disease.
    Grabicki M; Parysek H; Batura-Gabryel H; Brodnicka I
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():297-301. PubMed ID: 19218653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral muscle composition and health status in patients with COPD.
    Montes de Oca M; Torres SH; Gonzalez Y; Romero E; Hernández N; Mata A; Tálamo C
    Respir Med; 2006 Oct; 100(10):1800-6. PubMed ID: 16545558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What predicts change in pulmonary function and quality of life in asthma or COPD?
    Hesselink AE; van der Windt DA; Penninx BW; Wijnhoven HA; Twisk JW; Bouter LM; van Eijk JT
    J Asthma; 2006 Sep; 43(7):513-9. PubMed ID: 16939991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.